AkzoNobel opens new highly energy efficient membrane electrolysis plant in the industrial heart of Germany
AkzoNobel today inaugurated its new, highly efficient chlorine membrane electrolysis plant in the Rhein-Main area, Germany. The Frankfurt-based, state-of-the-art plant is the result of a major conversion and expansion project begun in 2011 and involving a €140 million investment by the company. Capacity has been increased by 50 percent whilst at the same time reducing the plant’s overall ecological footprint by some 20 percent.
"This investment in our Specialty Chemicals business highlights the steps we are taking to strengthen our market positions and further improve our performance as a company," said AkzoNobel CEO Ton Büchner. "We are constantly looking for new and innovative ways to improve our operational efficiency, drive our sustainability agenda and improve our service to customers."
Added Werner Fuhrmann, the company’s Executive Committee member responsible for Specialty Chemicals: "This plant produces building blocks for the manufacture of products we all use on a daily basis ranging from pharmaceuticals and tooth paste to door and window frames. By radically improving our efficiency and increasing our use of renewable energy, we can take significant steps in making these everyday essentials even more sustainable."
To mark the inauguration, a special event is being held today for employees, customers and other business partners. It will be attended by both Ton Büchner and Werner Fuhrmann, as well as Tarek Al-Wazir, Minister for Economy, Energy, Transport and Regional Development for the federal state of Hessen who stated: "The new chlorine production facility of AkzoNobel Industrial Chemicals is a good example that economy and ecology are compatible; and it is a strong signal for the strengthening of the chemical cluster Hessen."
The facility has been converted to the latest generation membrane technology. Radical efficiency improvements will reduce energy consumption by 30 percent per ton of product. Boosting chlorine production capacity up to 250 kilotons per year will also reinforce the company’s leading positions in Europe's chlor-alkali markets.
Work at Frankfurt started in 2011, with commercial production from the new plant expected to come on stream in the next few weeks. The site is one of three chlorine plants operated by AkzoNobel in Germany, the other two being located in Bitterfeld and Ibbenbüren.
Products from the salt-chlorine chain, including chlorine, caustic lye, and derivatives including MCA and chloromethanes, are essential basic chemicals and are used in countless everyday products and processes, ranging from water disinfection to clothing, amongst other things in the manufacture of epoxies, polyurethanes, polycarbonates, PVC and titanium dioxide. They are also used in the manufacture of more than two thirds of all pharmaceuticals.
Contact for this publication
Categories
Investments
Chemical substances
Countries
Companies
Latest news
Fluor Awarded Contract for Front-End Engineering and Design of Carbon Capture and Storage Solution at Heidelberg Materials Facility in Germany
Fluor will be responsible for design integration of several decarbonization technologies at the Geseke cement production facility. Construction is planned to start in 2026, with commissioning three...
Enaon (Italgas Group): €1 Billion Investment by 2030 to Support Greece’s Ecological Transition
This program will be executed by its subsidiary Enaon, focusing on four main pillars to support Greece’s ongoing ecological transition:
BASF in Lemförde expands sustainable product portfolio
BASF in Lemförde receives certification according to ISCC PLUS and successfully completes recertification according to REDcert. Mass balance approach enables the production of more sustainable poly...
Arkema finalizes the acquisition of Dow’s flexible packaging laminating adhesives business
With annual sales of around US$250 million, Dow’s flexible packaging laminating adhesives business offers a broad range of high-quality solutions in food and medical applications, as well as for in...